CVS:NYE-CVS Health Corporation (USD)

EQUITY | Healthcare Plans | New York Stock Exchange

Last Closing

USD 59.32

Change

-0.71 (-1.18)%

Market Cap

USD 78.05B

Volume

8.70M

Analyst Target

USD 78.78
Analyst Rating

N/A

ducovest Verdict

Verdict

About

CVS Health Corp iis an integrated pharmacy health care provider. The Company has three segments: Pharmacy Services, Retail Pharmacy and Corporate.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-08-02 )

Largest Industry Peers for Healthcare Plans

Symbol Name Price(Change) Market Cap
UNH UnitedHealth Group Incorporate..

N/A

USD 545.00B
ELV Elevance Health Inc

N/A

USD 129.14B
CNC Centene Corp

N/A

USD 41.47B
MOH Molina Healthcare Inc

N/A

USD 20.50B
OSCR Oscar Health Inc

N/A

USD 4.43B
NEUE NeueHealth Inc

N/A

USD 0.05B
CI Cigna Corp

N/A

N/A
HUM Humana Inc

N/A

N/A

ETFs Containing CVS

WBIY WBI Power Factor® High D.. 4.57 % 0.70 %

N/A

USD 0.06B
CFCV 3.58 % 0.00 %

N/A

N/A
UVAL:SW SPDR® MSCI USA Value UCI.. 2.45 % 0.00 %

N/A

USD 0.13B
LUSC:LSE SPDR Barclays 10+ U.S. Co.. 0.43 % 0.00 %

N/A

N/A
LCRP:LSE SPDR Barclays 10+ U.S. Co.. 0.42 % 0.00 %

N/A

USD 0.09B
SUSC:LSE SPDR Barclays 0-3 Year US.. 0.41 % 0.00 %

N/A

N/A
SYBN:F SPDR Barclays 10+ U.S. Co.. 0.37 % 0.00 %

N/A

USD 0.10B
SYBN:XETRA SPDR Barclays 10+ U.S. Co.. 0.37 % 0.00 %

N/A

USD 0.10B
SYBR:F SSgA SPDR ETFs Europe I P.. 0.30 % 0.00 %

N/A

USD 0.23B
SYBR:XETRA SPDR Barclays 3-10 U.S. C.. 0.30 % 0.00 %

N/A

USD 0.23B
IUCB:SW SPDR® Bloomberg 1-10 Yea.. 0.30 % 0.00 %

N/A

USD 0.30B
AGGY WisdomTree Yield Enhanced.. 0.00 % 0.12 %

N/A

USD 0.94B
BSCP Invesco BulletShares 2025.. 0.00 % 0.10 %

N/A

N/A
CVY Invesco Zacks Multi-Asset.. 0.00 % 0.65 %

N/A

USD 0.12B
ESGF 0.00 % 0.40 %

N/A

N/A
ESGL ESGL Holdings Limited Ord.. 0.00 % 0.40 %

N/A

USD 0.05B
IBDL 0.00 % 0.10 %

N/A

N/A
IHF iShares U.S. Healthcare P.. 0.00 % 0.43 %

N/A

N/A
ILTB iShares Core 10+ Year USD.. 0.00 % 0.06 %

N/A

USD 0.60B
LQD iShares iBoxx $ Investmen.. 0.00 % 0.15 %

N/A

N/A
SPLB SPDR Barclays Long Term C.. 0.00 % 0.08 %

N/A

USD 0.95B
IG Principal Exchange-Traded.. 0.00 % 0.26 %

N/A

USD 0.09B
IGLB iShares 10+ Year Investme.. 0.00 % 0.10 %

N/A

USD 2.64B
IBDT iShares iBonds Dec 2028 T.. 0.00 % 0.10 %

N/A

USD 2.17B
RTH VanEck Retail ETF 0.00 % 0.35 %

N/A

N/A
RWL Invesco S&P 500 Revenue E.. 0.00 % 0.39 %

N/A

N/A
SLQD iShares 0-5 Year Investme.. 0.00 % 0.06 %

N/A

USD 2.11B
SPVU Invesco S&P 500® Enhance.. 0.00 % 0.16 %

N/A

N/A
VVL:CA Vanguard Global Value Fac.. 0.00 % 0.40 %

N/A

N/A
ICAN 0.00 % 0.50 %

N/A

N/A
UC84:LSE UBS Barclays US Liquid Co.. 0.00 % 0.00 %

N/A

USD 0.09B
UVAL:LSE SPDR® MSCI USA Value UCI.. 0.00 % 0.00 %

N/A

USD 0.14B
VVAL:LSE 0.00 % 0.00 %

N/A

N/A
USVL:LSE SPDR® MSCI USA Value UCI.. 0.00 % 0.00 %

N/A

USD 0.14B
ZPRU:F SSgA SPDR ETFs Europe II .. 0.00 % 0.00 %

N/A

USD 0.13B
VGVL:XETRA 0.00 % 0.00 %

N/A

N/A
ZPRU:XETRA SPDR® MSCI USA Value UCI.. 0.00 % 0.00 %

N/A

USD 0.13B
GBLO 0.00 % 0.00 %

N/A

N/A
NVQ 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Healthcare Plans) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -24.87% 13% F 7% C-
Dividend Return 2.53% 100% F 58% F
Total Return -22.35% 13% F 8% B-
Trailing 12 Months  
Capital Gain -18.62% 25% F 13% F
Dividend Return 3.57% 100% F 52% F
Total Return -15.05% 25% F 13% F
Trailing 5 Years  
Capital Gain 6.48% 17% F 51% F
Dividend Return 19.95% 100% F 71% C-
Total Return 26.43% 17% F 53% F
Average Annual (5 Year Horizon)  
Capital Gain 4.00% 25% F 55% F
Dividend Return 6.79% 25% F 55% F
Total Return 2.79% 100% F 57% F
Risk Return Profile  
Volatility (Standard Deviation) 25.78% 25% F 40% F
Risk Adjusted Return 26.35% 38% F 47% F
Market Capitalization 78.05B N/A N/A N/A N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Healthcare Plans) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 15.90 N/A N/A
Price/Book Ratio N/A N/A N/A
Price / Cash Flow Ratio N/A N/A N/A
Price/Free Cash Flow Ratio N/A N/A N/A
Management Effectiveness  
Return on Equity N/A N/A N/A
Return on Invested Capital N/A N/A N/A
Return on Assets N/A N/A N/A
Debt to Equity Ratio N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector